# Heliox-Driven Racemic Epinephrine in Treatment of Bronchiolitis in Pediatric ED Patients

> **NCT00116584** · PHASE3 · COMPLETED · sponsor: **University of Louisville** · enrollment: 72 (actual)

## Conditions studied

- Bronchiolitis

## Interventions

- **DRUG:** heliox
- **DRUG:** oxygen

## Key facts

- **NCT ID:** NCT00116584
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2008-03
- **Final completion:** 2011-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2020-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00116584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00116584, "Heliox-Driven Racemic Epinephrine in Treatment of Bronchiolitis in Pediatric ED Patients". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00116584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*